| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.419 | 6.136 | 17.640 | 13.929 | 8.604 | 23.029 | 37.502 | 39.346 | 34.487 |
| Total Income - EUR | - | 3.419 | 6.136 | 17.640 | 14.056 | 8.618 | 23.030 | 37.508 | 39.349 | 34.489 |
| Total Expenses - EUR | - | 230 | 914 | 747 | 101 | 61 | 1.281 | 1.699 | 8.497 | 9.162 |
| Gross Profit/Loss - EUR | - | 3.189 | 5.223 | 16.892 | 13.954 | 8.557 | 21.748 | 35.808 | 30.852 | 25.327 |
| Net Profit/Loss - EUR | - | 3.087 | 5.038 | 16.363 | 13.534 | 8.317 | 21.140 | 34.982 | 30.478 | 24.313 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Cardiotreat Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 699 | 503 | 306 |
| Current Assets | - | 3.170 | 5.337 | 16.831 | 13.747 | 8.460 | 21.390 | 34.695 | 31.808 | 25.734 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 209 | 263 | 481 | 8.147 | 1.009 | 3.447 | 28.083 | 26.514 | 17.480 |
| Cash | - | 2.961 | 5.074 | 16.350 | 5.600 | 7.450 | 17.943 | 6.611 | 5.294 | 8.255 |
| Shareholders Funds | - | 3.131 | 5.129 | 16.434 | 13.607 | 8.381 | 21.250 | 35.209 | 30.553 | 24.380 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 39 | 208 | 398 | 140 | 79 | 140 | 185 | 1.757 | 1.661 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cardiotreat Srl